scispace - formally typeset
S

Shu-Yang Wang

Researcher at Southern Medical University

Publications -  25
Citations -  930

Shu-Yang Wang is an academic researcher from Southern Medical University. The author has contributed to research in topics: Metastasis & Colorectal cancer. The author has an hindex of 14, co-authored 21 publications receiving 668 citations.

Papers
More filters
Journal ArticleDOI

MicroRNA‐30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2

TL;DR: Functional and mechanistic links between miRNA‐30b and oncogene KRAS, PIK3CD and BCL2 in the pathogenesis of CRC were revealed and Restoration of miR‐30B expression may represent a promising therapeutic approach for targeting malignant CRC.
Journal ArticleDOI

Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340

TL;DR: circ_001680 may be a promising diagnostic and prognostic marker to determine the success of irinotecan-based chemotherapy in colorectal carcinoma through BMI1 upregulation.
Journal ArticleDOI

MicroRNA-224 sustains Wnt/β-catenin signaling and promotes aggressive phenotype of colorectal cancer

TL;DR: Mechanistic links between miR-224 and Wnt/β-catenin in the pathogenesis of CRC through modulation of GSK3β and SFRP2 are showed.
Journal ArticleDOI

FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways

TL;DR: It is revealed that both high expression and nuclear localization of FOXC2 were correlated to aggressive characteristics and poor survival of patients with CRC, suggesting that FoxC2 plays an essential role in CRC progression and may serve as a valuable clinical prognostic marker of this disease.